Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6.
about
Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in Egypt.Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA.Safety and efficacy of sofosbuvir-based treatment of acute hepatitis C in end-stage renal disease patients undergoing haemodialysis.
P2860
Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Systematic review: cost-effect ...... of hepatitis C genotypes 2-6.
@en
type
label
Systematic review: cost-effect ...... of hepatitis C genotypes 2-6.
@en
prefLabel
Systematic review: cost-effect ...... of hepatitis C genotypes 2-6.
@en
P2860
P50
P356
P1476
Systematic review: cost-effect ...... of hepatitis C genotypes 2-6.
@en
P2860
P304
P356
10.1111/APT.14271
P407
P577
2017-08-24T00:00:00Z